Amanote Research
Register
Sign In
A Phase I Study of Intravenous Liposomal Daunorubicin (DaunoXome) in Paediatric Patients With Relapsed or Resistant Solid Tumours
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6603288
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
August 1, 2006
Authors
S Lowis
I Lewis
A Elsworth
C Weston
F Doz
G Vassal
R Bellott
J Robert
F Pein
S Ablett
R Pinkerton
D Frappaz
Publisher
Springer Science and Business Media LLC
Related search
Phase I Study of Romidepsin and Liposomal Doxorubicin in Relapsed or Refractory T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase I Study of TAS-102 Treatment in Japanese Patients With Advanced Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
Phase I Study of CC-486 Alone and in Combination With Carboplatin or Nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Study of E7080, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
A Phase II Study of Docetaxel in Patients With Relapsed and Refractory Ewing's Tumours
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
Cyclosporin a and Doxorubicin-Ifosfamide in Resistant Solid Tumours: A Phase I and an Immunological Study
British Journal of Cancer
Cancer Research
Oncology
A Phase I Dose-Escalation Study of Intravenous Panobinostat in Patients With Lymphoma and Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Continuous-Infusion Verapamil With Etoposide in Relapsed or Resistant Paediatric Cancers
British Journal of Cancer
Cancer Research
Oncology
A Phase I Study of Pemetrexed (LY231514) Supplemented With Folate and Vitamin B12 in Japanese Patients With Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
